According to research presented this week at the American College of Rheumatology Annual Meeting, researchers have identified three potentially modifiable risk factors and one protective medication that may improve the health of people living with lupus.
Researchers from the University of California and Brigham and Women’s Hospital in Boston recently examined adherence among Medicaid beneficiaries with lupus to prescribed medications and found the patients were not following treatment plans, putting themselves at risk for poor outcomes.
A new study summarizes the best available evidence regarding the risk of heart disease and stroke among people with lupus.
Photosensitivity or abnormal light sensitivity is very complex and is a major symptom of lupus. Now, a new, small study sheds more light on photosensitivity among people with lupus. Learn more.
Cell based therapies are a growing interest in all areas of medicine as they are viewed as long term solutions rather than temporary fixes. A recent journal article highlights progress made in better understanding the potential for two basic types of adult stem cells.
Lupus nephritis, which can damage and scar the kidneys, is one of the most common and serious complications of lupus. This new study suggests that with the right induction regimen, it may be possible to avoid maintenance (long-term) treatment with oral steroids.
A new study conducted at Cincinnati Children’s Hospital Medical Center (CCHMC) suggests that neuroimaging methods such as functional magnetic resonance imaging (fMRI) may help identify biomarkers for children with NPSLE, particularly those with cognitive impairments.
People with lupus who were treated with hydroxychloroquine (HCQ), an anti-malarial drug, early after a diagnosis of lupus had less cumulative organ damage at three years after diagnosis than those who did not receive HCQ, according to a new analysis.